文章摘要
方鸽,鲁科达.鲁科达运用益气养阴祛风方治疗IgA肾病的经验浅析[J].浙江中医药大学学报,2024,48(2):197-200.
鲁科达运用益气养阴祛风方治疗IgA肾病的经验浅析
Analysis of LU Keda’s Experience in Treating IgA Nephropathy with Yiqi Yangyin Qufeng Prescription
DOI:10.16466/j.issn1005-5509.2024.02.012
中文关键词: IgA肾病  益气养阴祛风方  仝小林  态靶辨证  态靶结合  临床经验  鲁科达
英文关键词: IgA nephropathy  Yiqi Yangyin Qufeng Prescription  TONG Xiaolin  state target syndrome differentiation  state target binding  clinical experience  LU Keda
基金项目:浙江省中医药科技计划重点研究项目(2020ZZ008)
作者单位
方鸽 衢州市第三医院 浙江衢州 324002 
鲁科达 浙江中医药大学附属第三医院 
摘要点击次数: 324
全文下载次数: 204
中文摘要:
      [目的] 探讨鲁科达教授运用益气养阴祛风方治疗IgA肾病的临床经验。[方法] 通过跟师门诊,查阅IgA肾病相关资料文献,总结鲁师运用益气养阴祛风方治疗IgA肾病的临床经验,并提供医案一则加以佐证。[结果] 鲁师指出,早期IgA肾病患者素体脾肾亏虚,易受风邪侵袭,运用仝小林院士“态靶结合”的辨证组方思想,以“气阴两虚证”为态,理化指标“蛋白尿、血尿”为靶,自拟益气养阴祛风方。所举医案为IgA肾病早期,辨证为气阴两虚证,治以健脾补气、养阴生津兼以祛风,以益气养阴祛风方加减治疗,颇有疗效。[结论] 鲁师从“态靶辨证”角度确立方药治疗IgA肾病的经验,值得学习并传承。
英文摘要:
      [Objective] To explore Professor LU Keda’s clinical experience in treating IgA nephropathy with Yiqi Yangyin Qufeng prescription. [Methods] Through outpatient learning with teacher, consulting IgA nephropathy related literature, Professor LU’s clinical experience in treating IgA nephropathy with Yiqi Yangyin Qufeng Prescription was summarized, and one medical case was provided to support the treatment. [Results] Professor LU points out that the early IgA nephropathy patients are deficient in spleen and kidney, and always invaded by wind easily. He applies the thought of syndrome differentiation and prescription called “state target binding” from Academician TONG Xiaolin, taking “Qi and Yin deficiency syndrome” as the state, and the physical and chemical indexes “proteinuria and hematuria” as the target, using Yiqi Yangyin Qufeng Prescription for treatment. The medical case mentioned later was identified as early-stage IgA nephropathy, belonged to Qi and Yin deficiency syndrome. The treatment was to invigorate the spleen and tonify Qi, nourish Yin and promote body fluid and dispel wind. It had great curative effect by using Yiqi Yangyin Qufeng Prescription. [Conclusion] Professor LU’s experience in establishing the treatment of IgA nephropathy from the perspective of “state target syndrome differentiation” is worth learning and inheriting.
查看全文   查看/发表评论  下载PDF阅读器
关闭